This year in the United States, over 22,000 people will be diagnosed with a primary brain or spinal tumor. Of these, more than 13,000, many of them younger than 21 years old, will die of their disease. New treatment modalities are critical in the battle against cancer. Our focus in the Neuro-Oncology Research Laboratory is on brain tumor therapy and therapy resistance.
Our work consists mainly of translational research to develop novel adjuvant therapies for the treatment of brain tumors. We also use various molecular and molecular genetic techniques to investigate why current therapies sometimes fail.
Scheck Laboratory Staff
- Eric C. Woolf (Graduate Student, SSBTR Fellow)
- The Scheck Laboratory includes 6-8 undergraduate and high school students year round.